First Edition: January 3, 2023

Linda Rider

Today’s early morning highlights from the major news organizations. AP: Probe: Alzheimer’s Drug Approval ‘Rife With Irregularities’ The Food and Drug Administration’s contentious approval of a questionable Alzheimer’s drug took another hit Thursday as congressional investigators called the process “rife with irregularities.” (12/29) Reuters: Congressional Report: U.S. FDA Broke Own […]